BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 25528769)

  • 1. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
    Lu K; Dong JL; Fan WJ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8210-8219. PubMed ID: 30556860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
    Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
    Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
    Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
    Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
    Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
    Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.
    Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E
    Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
    Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
    World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells.
    Han M; Xu W
    Tumour Biol; 2017 Jul; 39(7):1010428317718404. PubMed ID: 28718375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
    Nam EH; Lee Y; Moon B; Lee JW; Kim S
    Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
    Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.
    Yamada N; Sugai T; Eizuka M; Tsuchida K; Sugimoto R; Mue Y; Suzuki M; Osakabe M; Uesugi N; Ishida K; Otsuka K; Matsumoto T
    Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
    Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
    J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
    Wang J; Wang X; Liu F; Fu Y
    Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelio-mesenchymal transitional attributes in oral sub-mucous fibrosis.
    Das RK; Anura A; Pal M; Bag S; Majumdar S; Barui A; Chakraborty C; Ray AK; Sengupta S; Paul RR; Chatterjee J
    Exp Mol Pathol; 2013 Dec; 95(3):259-69. PubMed ID: 23994666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWIST1 promoter methylation is associated with prognosis in tonsillar squamous cell carcinoma.
    Kwon MJ; Kwon JH; Nam ES; Shin HS; Lee DJ; Kim JH; Rho YS; Sung CO; Lee WJ; Cho SJ
    Hum Pathol; 2013 Sep; 44(9):1722-9. PubMed ID: 23664538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.